Case presentation
At admission, the patient showed obviously positive symptoms. She urgently underwent a drug concentration test, and was considered “drug intoxication”. She was given an emergency infusion to increase drug excretion. The drug treatment of the patient was adjusted. After pharmacogenomic examination, we found this patient was a CYP1A2 ultra-rapid metabolizer. At discharge, the clinical symptoms of the patient have decreased, and her condition was stable.